How many patents does
Immunogen have?
patents
1,907
families
138
granted
404
applications
1,503
US
331
EP
187
JP
128
WO
125
CN
113
KR
85
RoW
938
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Immunogen
Top ten assignees appearing on patents
2009 - 2018
| immunogen | 1501 |
| biotest | 96 |
| genentech | 59 |
| imclone | 23 |
| debiopharm international | 13 |
| immungene | 13 |
| janssen biotech | 8 |
| millennium pharmaceuticals | 7 |
| sanofi | 6 |
| centocor | 5 |
2018
| immunogen | 158 |
| debiopharm international | 9 |
| biotest | 7 |
| millennium pharmaceuticals | 5 |
| macrogenics | 2 |
| merck & company | 2 |
| health research | 1 |
| imclone | 1 |
| sanofi | 1 |
| genentech | 1 |
Immunogen
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| cytotoxic benzodiazepine derivatives | 89 | 2011 |
| folate receptor 1 antibodies and immunoconjugates and uses thereof | 76 | 2010 |
| humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies | 71 | 1999 |
| novel benzodiazepine derivatives | 58 | 2009 |
| cross-linkers and their uses | 54 | 2008 |
| ca6 antigen-specific cytotoxic conjugate and methods of using the same | 52 | 2003 |
| method of targeting specific cell populations using cell-binding agent maytansinoid conj… 🛈 | 52 | 2003 |
| methods for increasing efficacy of folr1 cancer therapy | 47 | 2011 |
| process for preparing maytansinoid antibody conjugates | 45 | 2005 |
| cd37-binding molecules and immunoconjugates thereof | 45 | 2010 |